SL STRATEGIES, LLC

Lobbying for PARTNER THERAPEUTICS · biotechnology company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $45,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response

Budget/Appropriations

Fiscal Year 2026 HHS appropriations for rad/nuc preparedness and response, specifically within BARDA and the Strategic National Stockpile.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.